|
JP4129993B2
(ja)
|
1996-01-16 |
2008-08-06 |
ブリストル―マイヤーズ・スクイブ・カンパニー |
ミクロソーム・トリグリセリド転移プロテインの立体配座制限芳香族抑制剤および方法
|
|
US20040006011A1
(en)
*
|
1996-07-12 |
2004-01-08 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US20020168761A1
(en)
*
|
2000-01-24 |
2002-11-14 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US6174905B1
(en)
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
US5760246A
(en)
*
|
1996-12-17 |
1998-06-02 |
Biller; Scott A. |
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
|
|
US6307049B1
(en)
|
1998-09-30 |
2001-10-23 |
The Procter & Gamble Co. |
Heterocyclic 2-substituted ketoamides
|
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
|
CZ2002961A3
(cs)
|
1999-09-17 |
2002-08-14 |
Millennium Pharmaceuticals, Inc. |
Benzamidy a příbuzné sloučeniny pro inhibici faktoru Xa
|
|
US20020065303A1
(en)
|
2000-02-01 |
2002-05-30 |
Bing-Yan Zhu |
Bivalent phenylene inhibitors of factor Xa
|
|
US6403588B1
(en)
*
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
|
EP1277754B8
(en)
|
2000-04-27 |
2005-09-28 |
Astellas Pharma Inc. |
Imidazopyridine derivatives
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
WO2002026712A2
(en)
|
2000-09-29 |
2002-04-04 |
Millennium Pharmaceuticals, Inc. |
Quaternary amines and related inhibitors of factor xa
|
|
WO2002034748A1
(fr)
|
2000-10-24 |
2002-05-02 |
Sankyo Company, Limited |
Derives d'imidazopyridine
|
|
US7429599B2
(en)
|
2000-12-06 |
2008-09-30 |
Signal Pharmaceuticals, Llc |
Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
|
|
US7129242B2
(en)
|
2000-12-06 |
2006-10-31 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
|
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
|
SE0100569D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
New compounds
|
|
BR0207096A
(pt)
|
2001-02-20 |
2004-01-20 |
Astrazeneca Ab |
Uso de um composto, compostos, formulação farmacêutica, e, método de tratamento e/ou profilaxia de condições associadas com a inibição de glicogênio sintase quinase-3
|
|
CA2442654A1
(en)
|
2001-04-10 |
2002-10-10 |
Transtech Pharma, Inc. |
Probes, systems, and methods for drug discovery
|
|
KR20040018281A
(ko)
|
2001-06-21 |
2004-03-02 |
스미스클라인 비참 코포레이션 |
포진 바이러스 감염의 예방 및 치료를 위한 이미다조[1，２－α]피리딘 유도체
|
|
CA2450555A1
(en)
|
2001-06-25 |
2003-01-03 |
Merck & Co., Inc. |
(pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
|
|
EP1270551A1
(en)
|
2001-06-26 |
2003-01-02 |
Aventis Pharma Deutschland GmbH |
Urea derivatives with antiproteolytic activity
|
|
US7868204B2
(en)
*
|
2001-09-14 |
2011-01-11 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
US7244740B2
(en)
|
2001-10-05 |
2007-07-17 |
Smithkline Beecham Corporation |
Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
|
|
DE60225316T2
(de)
|
2001-11-13 |
2009-02-26 |
AXYS Pharmaceuticals, Inc., South San Francisco |
Cyanoalkylamino-derivate als protease-hemmer
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
JP2003313126A
(ja)
|
2002-04-23 |
2003-11-06 |
Sankyo Co Ltd |
イミダゾピリジン誘導体を有効成分とする医薬
|
|
JP2004002826A
(ja)
|
2002-04-24 |
2004-01-08 |
Sankyo Co Ltd |
高分子イミダゾピリジン誘導体
|
|
GB0212049D0
(en)
|
2002-05-24 |
2002-07-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US20040034084A1
(en)
|
2002-05-24 |
2004-02-19 |
Celgene Corporation |
Methods for using JNK inhibitors for treating or preventing disease-related wasting
|
|
CA2388358A1
(en)
|
2002-05-31 |
2003-11-30 |
Voiceage Corporation |
A method and device for multi-rate lattice vector quantization
|
|
JP3725105B2
(ja)
*
|
2002-08-30 |
2005-12-07 |
株式会社東芝 |
二次電池の過放電防止回路及び二次電池の過放電防止法
|
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
|
EP1551795A1
(en)
|
2002-10-17 |
2005-07-13 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
US20040087642A1
(en)
|
2002-10-24 |
2004-05-06 |
Zeldis Jerome B. |
Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
|
|
US20040092568A1
(en)
|
2002-10-31 |
2004-05-13 |
Zeldis Jerome B. |
Methods for the treatment, prevention and management of macular degeneration
|
|
WO2004048343A1
(en)
|
2002-11-28 |
2004-06-10 |
Schering Aktiengesellschaft |
Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
|
|
US20050019366A1
(en)
|
2002-12-31 |
2005-01-27 |
Zeldis Jerome B. |
Drug-coated stents and methods of use therefor
|
|
US7135493B2
(en)
*
|
2003-01-13 |
2006-11-14 |
Astellas Pharma Inc. |
HDAC inhibitor
|
|
TW200424174A
(en)
|
2003-02-06 |
2004-11-16 |
Hoffmann La Roche |
New TP diamide
|
|
US7208491B2
(en)
|
2003-02-07 |
2007-04-24 |
Hoffmann-La Roche Inc. |
N-monoacylated o-phenylenediamines
|
|
WO2004076452A1
(en)
|
2003-02-26 |
2004-09-10 |
Merck Sharp & Dohme Limited |
5,8-DIFLUOROIMIDAZO[1,2-a]PYRIDINES AS GABA-A α2/α3 LIGANDS FOR TREATING ANXIETY AND/OR DEPRESSION
|
|
US7320989B2
(en)
*
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
EP1603900A4
(en)
|
2003-03-06 |
2008-08-20 |
Merck & Co Inc |
IMIDAZOPYRIDIN COMPOUNDS WITH EFFECT AGAINST PROTOZOEN
|
|
PT1611088E
(pt)
|
2003-04-07 |
2009-09-24 |
Pharmacyclics Inc |
Hidroxamatos como agentes terapêuticos
|
|
CA2521915A1
(en)
|
2003-04-15 |
2004-10-28 |
Pfizer Inc. |
Alpha substituted carboxylic acid as ppar modulators
|
|
US20050187266A1
(en)
|
2003-04-15 |
2005-08-25 |
Pfizer Inc |
Alpha substituted carboxylic acids
|
|
US20050234066A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Agouron Pharmaceuticals, Inc. |
Alpha substituted carboxylic acids
|
|
CN102584813B
(zh)
|
2003-05-14 |
2016-07-06 |
Ngc药物公司 |
化合物及其在调节淀粉样蛋白β中的用途
|
|
WO2005006945A2
(en)
|
2003-07-03 |
2005-01-27 |
The Salk Institute For Biological Studies |
Methods for treating neural disorders and compounds useful therefor
|
|
AU2004276337B2
(en)
|
2003-09-24 |
2009-11-12 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
EP2210607B1
(en)
|
2003-09-26 |
2011-08-17 |
Exelixis Inc. |
N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer
|
|
EP1684690A4
(en)
|
2003-11-06 |
2008-10-15 |
Celgene Corp |
METHODS OF USE AND COMPOSITIONS COMPRISING A JNK INHIBITOR FOR THE TREATMENT AND MANAGEMENT OF ASBESTOS-RELATED DISEASES AND DISORDERS
|
|
US7524851B2
(en)
|
2003-12-05 |
2009-04-28 |
Robert Bosch Gesellschaft Fur Medizinische Forschung (Rbmf) |
Diagnostic methods for therapeutic compounds and methods for monitoring azathioprine therapy
|
|
US7429590B2
(en)
|
2003-12-10 |
2008-09-30 |
Merck & Co. Inc. |
Antiprotozoal imidazopyridine compounds
|
|
US7671181B2
(en)
|
2004-01-16 |
2010-03-02 |
Merck Sharp & Dohme Corp. |
Polynucleotides encoding coccidian parasite casein kinase I, a chemotherapeutic target for antiprotozoal agents
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
WO2005077368A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
DE102004008141A1
(de)
|
2004-02-19 |
2005-09-01 |
Abbott Gmbh & Co. Kg |
Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
|
|
US20070093492A1
(en)
*
|
2004-03-09 |
2007-04-26 |
Weir-Torn Jiaang |
Pyrrolidine derivatives
|
|
US7253204B2
(en)
*
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
AU2005225471B2
(en)
|
2004-03-26 |
2011-05-12 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
JP2007533730A
(ja)
|
2004-04-20 |
2007-11-22 |
アブ サイエンス |
筋炎および筋ジストロフィーを含む炎症性筋疾患を処置するためのｃ−ｋｉｔ阻害剤の使用法
|
|
NZ550114A
(en)
|
2004-04-20 |
2011-02-25 |
Transtech Pharma Inc |
Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
|
|
WO2005102318A1
(en)
|
2004-04-20 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating hiv related diseases
|
|
EP1742633A2
(en)
|
2004-04-23 |
2007-01-17 |
AB Science |
Use of c-kit inhibitors for treating fibrosis
|
|
WO2005102326A2
(en)
|
2004-04-23 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating renal diseases
|
|
US20080004279A1
(en)
|
2004-04-23 |
2008-01-03 |
Alain Moussy |
Use of C-Kit Inhibitors for Treating Plasmodium Related Diseases
|
|
MXPA06013315A
(es)
*
|
2004-05-17 |
2007-02-02 |
Tibotec Pharm Ltd |
1,5-dihidro-pirido[3,2-b]indol-2-onas 4-sustituidas.
|
|
US20070249628A1
(en)
|
2004-05-18 |
2007-10-25 |
Alain Moussy |
Use of Mast Cells Inhibitors for Treating Patients Exposed to Chemical or Biological Weapons
|
|
WO2005115304A2
(en)
|
2004-05-24 |
2005-12-08 |
Ab Science |
Use of c-kit inhibitors for treating fibrodysplasia
|
|
WO2005115385A1
(en)
|
2004-05-24 |
2005-12-08 |
Ab Science |
Use of c-kit inhibitors for treating acne
|
|
HRP20120327T1
(hr)
|
2004-07-28 |
2012-05-31 |
Janssen Pharmaceutica Nv |
Supstituirani indolil alkil amino derivati kao novi inhibitori histonske deacetilaze
|
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
|
AU2005295734A1
(en)
|
2004-10-15 |
2006-04-27 |
Biogen Idec Ma Inc. |
Methods of treating vascular injuries
|
|
JP2008520730A
(ja)
|
2004-11-23 |
2008-06-19 |
セルジーン・コーポレーション |
中枢神経系傷害の治療用ｊｎｋ阻害剤
|
|
BRPI0516915A
(pt)
|
2004-12-01 |
2008-03-11 |
Devgen Nv |
derivados de tiazol substituìdos por 5-carboxamido que interagem com canais de ìons, particularmante com canais de ìons da famìlia kv
|
|
US20090099160A1
(en)
|
2004-12-17 |
2009-04-16 |
David Andrews |
4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors
|
|
JPWO2006070943A1
(ja)
|
2004-12-28 |
2008-06-12 |
武田薬品工業株式会社 |
縮合イミダゾール化合物およびその用途
|
|
US20090048285A1
(en)
|
2005-01-19 |
2009-02-19 |
Benjamin Pelcman |
Pyrrolopyridines Useful in the Treatment of Inflammation
|
|
CA2600860A1
(en)
*
|
2005-03-09 |
2006-09-21 |
Merck & Co., Inc. |
Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
|
|
US20060223807A1
(en)
|
2005-03-29 |
2006-10-05 |
University Of Massachusetts Medical School, A Massachusetts Corporation |
Therapeutic methods for type I diabetes
|
|
WO2006108059A1
(en)
|
2005-04-06 |
2006-10-12 |
Exelixis, Inc. |
C-met modulators and methods of use
|
|
AU2006244203B2
(en)
|
2005-05-09 |
2012-05-03 |
Achillion Pharmaceuticals, Inc. |
Thiazole compounds and methods of use
|
|
JP4528918B2
(ja)
|
2005-06-21 |
2010-08-25 |
学校法人 関西大学 |
カルボキサミド誘導体
|
|
JP2008546802A
(ja)
*
|
2005-06-24 |
2008-12-25 |
ジェネラブズ テクノロジーズ インコーポレーティッド |
ウイルスを治療するためのヘテロアリール誘導体
|
|
US7309787B2
(en)
|
2005-07-13 |
2007-12-18 |
Allergan, Inc. |
Kinase inhibitors
|
|
EP1904065A2
(en)
|
2005-07-14 |
2008-04-02 |
AB Science |
Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma
|
|
CN101304736A
(zh)
|
2005-09-07 |
2008-11-12 |
雪兰诺实验室公司 |
治疗子宫内膜异位症的ikk抑制剂
|
|
RU2405770C2
(ru)
|
2005-09-27 |
2010-12-10 |
Сионоги Энд Ко., Лтд. |
Производное сульфонамида, обладающее антагонистической активностью в отношении рецептора pgd2
|
|
AU2006296386A1
(en)
|
2005-09-30 |
2007-04-05 |
Astrazeneca Ab |
Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
|
|
UY29827A1
(es)
|
2005-10-03 |
2007-05-31 |
Astrazeneca Ab |
2-amina-pirimidina-4-(2-metil-1-(tetrahidro-2h-piran-4-il)-1-imidazol-5-y1) sustituidas y sus derivados, composiciones farmacéuticas que las contienen, procesos para su preparación y aplicaciones
|
|
ITMI20060296A1
(it)
|
2006-02-17 |
2007-08-18 |
Alberto Lodolo |
Dispositivo di intercettazione multifunzionale
|
|
CA2644933A1
(en)
*
|
2006-02-27 |
2007-09-07 |
Gilead Colorado, Inc. |
Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
|
|
WO2007127137A2
(en)
|
2006-04-26 |
2007-11-08 |
Merck & Co., Inc. |
Disubstituted aniline compounds
|
|
WO2009002534A1
(en)
*
|
2007-06-26 |
2008-12-31 |
Gilead Colorado, Inc. |
Imidazopyridinyl thiazolyl histone deacetylase inhibitors
|
|
JP5640005B2
(ja)
*
|
2008-07-14 |
2014-12-10 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｄａｃおよび／またはｃｄｋ阻害剤としてのイミダゾシルピリジン化合物
|
|
EP2303881A2
(en)
*
|
2008-07-14 |
2011-04-06 |
Gilead Sciences, Inc. |
Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases
|
|
KR20110038159A
(ko)
|
2008-07-28 |
2011-04-13 |
길리애드 사이언시즈, 인코포레이티드 |
사이클로알킬리덴 및 헤테로사이클로알킬리덴 히스톤 데아세틸라아제 억제제 화합물
|
|
ES2463826T3
(es)
*
|
2009-06-08 |
2014-05-29 |
Gilead Sciences, Inc. |
Compuestos inhibidores de HDAC de cicloalquilcarbamato benzamida anilina
|
|
CA2763786C
(en)
*
|
2009-06-08 |
2014-09-30 |
Gilead Sciences, Inc. |
Alkanoylamino benzamide aniline hdac inihibitor compounds
|